"Selenomethionine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diagnostic aid in pancreas function determination.
| Descriptor ID |
D012645
|
| MeSH Number(s) |
D02.712.700 D02.886.030.676.900 D12.125.166.676.900
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Selenomethionine".
Below are MeSH descriptors whose meaning is more specific than "Selenomethionine".
This graph shows the total number of publications written about "Selenomethionine" by people in this website by year, and whether "Selenomethionine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Selenomethionine" by people in Profiles.
-
Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer. Pancreas. 2015 Aug; 44(6):945-52.
-
Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature. Cancer Invest. 2013 Oct; 31(8):505-10.
-
Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature. Cancer Lett. 2011 Feb 28; 301(2):177-84.
-
Multiple methionine substitutions are tolerated in T4 lysozyme and have coupled effects on folding and stability. Biophys Chem. 2003; 100(1-3):325-40.